# Effects of an Intensified Treatment With ACE-I,ATA II and Statins in Alport Syndrome

> **NCT00309257** · PHASE2 · COMPLETED · sponsor: **Mario Negri Institute for Pharmacological Research** · enrollment: 9 (actual)

## Conditions studied

- Alport Syndrome

## Interventions

- **DRUG:** ACE I, ATA II and Statins
- **DRUG:** Benazepril, Valsartan and Fluvastatin

## Key facts

- **NCT ID:** NCT00309257
- **Lead sponsor:** Mario Negri Institute for Pharmacological Research
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2008-06
- **Final completion:** 2009-10
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2023-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00309257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00309257, "Effects of an Intensified Treatment With ACE-I,ATA II and Statins in Alport Syndrome". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00309257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*